Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-112509
Filing Date
2025-05-05
Accepted
2025-05-05 13:12:12
Documents
4
Period of Report
2025-05-05

Document Format Files

Seq Description Document Type Size
1 6-K d61420d6k.htm 6-K 9388
2 EX-99.1 d61420dex991.htm EX-99.1 10759
3 GRAPHIC g61420g0505203234349.jpg GRAPHIC 2601
4 GRAPHIC g61420g0505204226911.jpg GRAPHIC 1087
  Complete submission text file 0001193125-25-112509.txt   26743
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 25912062
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)